NVIDIA launched about two dozen new AI-powered, healthcare-focused tools at its 2024 GTC AI conference last week. The move into health care is an effort that's been under development for a decade and has significant revenue potential. Nvidia shares are up close to 100% year-to-date, and the biotech industry is an example of the untapped potential that investors are still bet on.